Ehsan Malek
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
Papers in
- Hematology 75
- Multiple Myeloma Research and Treatments 58
- Hematopoietic Stem Cell Transplantation 15
- Acute Myeloid Leukemia Research 9
- Oncology 37
- CAR-T cell therapy research 8
- Peptidase Inhibition and Analysis 8
- Co-authors
- James Joseph Driscoll (36 shared papers)James John Ignatz-Hoover (7 shared papers)Byung‐Gyu Kim (5 shared papers)Sajjeev Jagannathan (4 shared papers)Sung Hee Choi (1 shared paper)Marcos J. G. De Lima (50 shared papers)Muthulekha Swamydas (2 shared papers)Kenneth Carl Anderson (2 shared papers)
- Journals
- Transplantation and Cellular Therapy (25 papers)Blood (21 papers)Leukemia (5 papers)Oncotarget (4 papers)JCO Clinical Cancer Informatics (3 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Ehsan Malek
98 papers receiving 2.8k citations
Ehsan Malek's Hit Papers
Peers
Comparison fields: 5 of 104
- Hematology 1.4k
- Oncology 1.2k
- Immunology 414
- Cancer Research 274
- Molecular Biology 1.2k
Countries citing papers authored by Ehsan Malek
This map shows the geographic impact of Ehsan Malek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehsan Malek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehsan Malek more than expected).
Fields of papers citing papers by Ehsan Malek
This network shows the impact of papers produced by Ehsan Malek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehsan Malek. The network helps show where Ehsan Malek may publish in the future.
Co-authors
The 25 scholars most cited alongside Ehsan Malek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy Hit paper breakdown → | 2019 | 528 |
| 2 | Novel therapies emerging in oncology to target the TGF-β pathway Hit paper breakdown → | 2021 | 343 |
| 3 | 2019 | 215 | |
| 4 | 2014 | 165 | |
| 5 | 2018 | 156 | |
| 6 | 2019 | 126 | |
| 7 | 2016 | 118 | |
| 8 | 2015 | 95 | |
| 9 | 2022 | 89 | |
| 10 | 2014 | 75 | |
| 11 | 2020 | 56 | |
| 12 | 2016 | 50 | |
| 13 | 2019 | 39 | |
| 14 | 2014 | 39 | |
| 15 | 2017 | 38 | |
| 16 | 2021 | 38 | |
| 17 | 2019 | 37 | |
| 18 | 2019 | 37 | |
| 19 | 2015 | 34 | |
| 20 | 2018 | 33 |
About Ehsan Malek
Ehsan Malek is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Molecular Biology and Genetics, having authored 107 papers that have together received 2.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (58 papers), Protein Degradation and Inhibitors (21 papers), Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers), CAR-T cell therapy research (8 papers), Peptidase Inhibition and Analysis (8 papers) and Histone Deacetylase Inhibitors Research (7 papers). The work is most often cited by research in Hematology (1.4k citations), Oncology (1.2k citations), Immunology (414 citations), Cancer Research (274 citations) and Molecular Biology (1.2k citations). Ehsan Malek has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include James Joseph Driscoll, James John Ignatz-Hoover, Byung‐Gyu Kim, Sajjeev Jagannathan, Sung Hee Choi, Marcos J. G. De Lima, Muthulekha Swamydas, Kenneth Carl Anderson, Nikhil M. Vad and James H. Finke. Their work appears in journals such as Transplantation and Cellular Therapy, Blood, Leukemia, Oncotarget and JCO Clinical Cancer Informatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.